Fig. 1 · Structure

Documents & Downloads

L-371,257

Cat. No. A21219 CAS 162042-44-6

oxytocin receptor antagonist

L-371,257 is an orally bioavailable, non-blood-brain barrier penetrant, selective and competitive antagonist of oxytocin receptor (pA2=8.4) with high affinity at both the oxytocin receptor (Ki=19 nM) and vasopressin V1a receptor (Ki=3.7 nM).

In Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Biological Activity

Cellular Effect

Cell Line Activity Value Description Reference
CHO EC50 3200 nM Activity at human vasopressin V1a receptor expressed in CHO cells by NFAT-luciferase gene reporter assay [PMID: 20104850]
CHO EC50 37000 nM Activity at human vasopressin V2 receptor expressed in CHO cells by NFAT-luciferase gene reporter assay [PMID: 20104850]
CHO EC50 4.6 nM Activity at human oxytocin receptor expressed in CHO cells by NFAT-luciferase gene reporter assay [PMID: 20104850]

Specifications

Manufacturer Adooq Bioscience
Actions Antagonist
CAS Number 162042-44-6
Applications oxytocin receptor antagonist
Formula C28H33N3O6
Molecular Weight 507.58
Synonyms L-371257
SMILES
O=C(OC1)N(C2CCN(C(C3=C(OC)C=C(OC4CCN(C(C)=O)CC4)C=C3)=O)CC2)C5=C1C=CC=C5

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Added to your cart

View Cart Checkout
Loading...